Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Gilead Sciences Inc

+ Add to Watchlist

GILD:US

114.0800 USD 1.8100 1.61%

As of 20:10:00 ET on 06/01/2015.

Company Profile for Gilead Sciences Inc (GILD)

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

Contact Information

Gilead Sciences Inc

333 Lakeside Drive
Foster City, CA 94404
United States
Phone: 1-650-574-3000
Fax: 1-650-578-9264

Key Executives for Gilead Sciences Inc (GILD)

John C MartinChairman/CEOJohn F MilliganPresident/COO
Robin L WashingtonExec VP/CFOPaul R CarterExec VP:Commercial Operations
Gregg H AltonExec VP:Corp & Medical AffairsNorbert W BischofbergerExec VP:Research & Dev/CSO
Patrick O'BrienVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil